The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DMTomohiro Koga, Atsushi Kawakami, Keita Fujikawa et al.|Lara D. Veeken|2012Cited by 321
Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional studyKeita Fujikawa, Katsumi Eguchi, Atsushi Kawakami et al.|Scandinavian Journal of Rheumatology|2009Cited by 88
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositisYoshiro Horai, Atsushi Kawakami, Tomohiro Koga et al.|Modern Rheumatology|2014Cited by 85
Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and PlasmapheresisYuya Fujita, Atsushi Kawakami, Tomoki Origuchi et al.|Internal Medicine|2018Cited by 26
Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with RituximabYuya Fujita, Atsushi Kawakami, Shoichi Fukui et al.|Internal Medicine|2018Cited by 23